Revolutionizing Lung Cancer Detection with Cizzle Biotechnology’s Innovative Approach

Cizzle Biotechnology is setting new benchmarks in lung cancer screening with their innovative blood test, which utilizes the CIZ1B biomarker for early detection. Allan Syms discusses the significant advancements in a recent video, highlighting the key partnership in North America that ensures guaranteed revenue and collaboration with major cancer centers. Furthermore, the development of a finger-prick test aims to expand lung cancer screening, supported by non-dilutive funding to propel their reach into the UK and Europe.

Discover more about this transformative technology by watching the full video on our website.

Watch the Full Video: Cizzle Biotech’s Innovation in Lung Cancer Detection

Tell us how you want to grow.
Let’s get acquainted.


    Give us a call.
    Send us an email.
    Connect with us.